Immunological Characteristics of Non-Intensive Care Hospitalized COVID-19 Patients: A Preliminary Report

Abstract

The outbreak of coronavirus disease 2019 (COVID-19) is posing a threat to global health. This disease has different clinical manifestations and different outcomes. The immune response to the novel 2019 coronavirus is complex and involves both innate and adaptive immunity. In this context, cell-mediated immunity plays a vital role in effective immunity against SARS-CoV-2. Significant differences have been observed when comparing severe and non-severe patients. Since these immunological characteristics have not been fully elucidated, we aimed to use cluster analysis to investigate the immune cell patterns in patients with COVID-19 who required hospitalization but not intensive care. We identified four clusters of different immunological patterns, the worst being characterized by total lymphocytes, T helper lymphocytes CD4+ (CD4+), T cytotoxic lymphocytes CD8+ (CD8+) and natural killer (NK) cells below the normal range, together with natural killer lymphocyte granzyme < 50% (NK granzyme+) and antibody-secreting plasma cells (ASCs) equal to 0 with fatal outcomes. In the worst group, 50% of patients died in the intensive care unit. Moreover, a negative trend was found among four groups regarding total lymphocytes, CD4+, CD8+ and B lymphocytes (p < 0.001, p < 0.005, p < 0.000, p < 0.044, respectively). This detailed analysis of immune changes may have prognostic value. It may provide a new perspective for identifying subsets of COVID-19 patients and selecting novel prospective treatment strategies. Notwithstanding these results, this is a preliminary report with a small sample size, and our data may not be generalizable. Further cohort studies with larger samples are necessary to quantify the prognostic value’s weight, according to immunological changes in COVID-19 patients, for predicting prognoses and realizing improvements in clinical conditions.

Protective Effect of Vitamin D Supplementation on COVID-19-Related Intensive Care Hospitalization and Mortality: Definitive Evidence from Meta-Analysis and Trial Sequential Analysis

“…In this sense, Iwasaki and Medzhitov showed that the level of IL-6 was markedly higher in severe cases than in mild and moderate cases. Still, the levels of CD4+ T cells, CD8+ T cells, and NK cells were decreased, indicating immunosuppression in severe COVID-19 [ 61 , 62 , 63 ].…”

Case report: A case of Acute Macular Neuroretinopathy secondary to Influenza A virus during Long COVID

“…However, further investigation is required to ascertain the significance of these differences. Recent research has further uncovered that residual SARS-CoV-2 can persist in various organ systems ( 17 – 20 ), thereby increasing oxidative stress response ( 21 ) and cytotoxic effects ( 7 ), which may contribute to LC development. The prevalence of LC is estimated to exceed 10% ( 22 , 23 ), with some reports suggesting that it could impact 50–70% ( 24 , 25 ) of hospitalized patients.…”

An Overview of Systematic Reviews of the Role of Vitamin D on Inflammation in Patients with Diabetes and the Potentiality of Its Application on Diabetic Patients with COVID-19

“…Adaptive immunity is the key factor in the complete eradication of the virus [ 4 ]; this immune pathway needs 4 to 7 days to be activated after the occurrence of the infection. If an effective adaptive antiviral response is not generated in time to suppress the virus, innate immune responses will potentiate but are unable to effectively eradicate the virus, and this also leads to systemic inflammatory responses with the irrepressible release of inflammatory cytokines [ 75 , 76 , 77 , 78 ]. Elderly patients and those with chronic diseases need a longer period of time to generate adaptive and innate immune responses because of cell senescence.…”